Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
322 |
|
| Actual shortage: | 11 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (2%) | |
| Resolved: | 306 (95%) | |
Discontinuation Reports |
1 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 1 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
48 (15%) |
|
Overdue reports |
4 (36%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2019-07-05 | 2019-08-02 | 88607 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2019-08-06 | 2019-08-24 | 91024 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2019-09-13 | 2019-10-02 | 93918 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2021-12-10 | 2022-01-17 | 150947 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2022-02-08 | 2022-04-13 | 154476 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2022-04-13 | 2023-03-01 | 158765 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-07-30 | 2021-09-16 | 143318 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-02-28 | 2022-06-17 | 155735 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-05-12 | 181142 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-08-11 | 2024-09-20 | 201627 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2024-06-10 | 2024-07-02 | 230030 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-07-30 | 2021-08-28 | 143321 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-11-30 | 2022-01-17 | 150232 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2022-05-15 | 2022-08-09 | 160653 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2022-09-01 | 2022-10-02 | 168499 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2023-01-16 | 2023-05-01 | 181139 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2024-06-10 | 2024-07-19 | 230033 |
| INTRALIPID 20% | 20% | EMULSION | Resolved | 2021-09-10 | 2021-10-22 | 145481 |
| ISOFLURANE USP | 99.9% | LIQUID | Resolved | 2024-07-31 | 2024-08-10 | 234157 |
| ISOFLURANE USP | 99.9% | LIQUID | Resolved | 2024-07-31 | 2024-08-10 | 234160 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
Showing 1 to 1 of 1